2
(Updates dateline, adds AbbVie-Iambic deal) Sept 21 (Reuters) – Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development, betting on new
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
